$PTEN

UBS Keeps Their Hold Rating on Patterson-UTI (PTEN)

UBS maintained a Hold rating on Patterson-UTI (PTEN) with a $13.00 price target. Morgan Stanley also rated it Hold, while RBC Capital kept a Buy rating. PTEN reported Q2 revenue of $1.23B and a net loss of $19.6M. Insider sentiment is negative, with CEO selling shares.

Original reporting
Published Oct 27, 2026, 6:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 7:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS Keeps Their Hold Rating on Patterson-UTI (PTEN) — source image
Decision brief

The 30-second read

$PTENBearishLow
01

Why it matters

The combination of unchanged analyst ratings and a sizable insider sell creates a bearish short‑term outlook for PTEN.

02

Market read

PTEN's stock may face near‑term downside pressure due to insider selling and lack of rating upgrades, with limited broader market impact.

03

What to watch

Recent quarterly loss narrowed significantly, and revenue grew year‑over‑year, which could support a longer‑term upside.

Relevance 4/10Novelty 3/10Timing: today

Background

Analyst coverage for Patterson‑UTI remains neutral with Hold ratings from UBS and Morgan Stanley, while RBC maintains a Buy. The latest earnings showed a narrowed loss and modest revenue growth.

Company-level read

Ticker impact

$PTENBearishMedium confidence
Context

UBS and Morgan Stanley maintain Hold ratings on Patterson-UTI and CEO William Hendricks sold 250,000 shares, indicating negative insider sentiment.

Expected impact

likely pressure as the market prices in insider selling and lack of rating upgrades.

Evidence & confidence

Insider sell of $3.2M by the CEO combined with unchanged Hold ratings signals limited upside and potential downside risk.

Market effects

Energy services sector may see modest sentiment drag from PTEN's insider activity.

North American energy service stocks could experience slight weakness.

Limited; impact confined to PTEN and its immediate peers.

Counterpoint

Despite insider selling, the Hold ratings may mask undervalued fundamentals and a potential rebound if oil demand improves.

Key entities

  • Patterson‑UTI Energy

    U.S. energy services provider (NASDAQ: PTEN).

  • William Hendricks

    President & CEO of PTEN who sold 250,000 shares.

Related articles

$LBRTLow

Liberty Energy, Green Plains, Murphy Oil, Patterson-UTI, and Texas Pacific Land Shares Are Soaring, What You Need To Know

Shares of Liberty Energy, Green Plains, Murphy Oil, Patterson-UTI, and Texas Pacific Land rose after crude oil prices climbed due to strikes on Saudi energy facilities. Brent crude futures rose $1.00 to over $98.00 a barrel, and WTI crude futures increased over $2.00 to $93.65 a barrel, according to Reuters. Higher oil prices benefit oil and gas producers by expanding profit margins and boosting cash flow.

$PTENMed

Patterson-UTI to fund 2026 dividend with adjusted free cash flow; $701M liquidity, low leverage

Patterson-UTI (PTEN) expects 2026 adjusted free cash flow to cover its annual dividend and plans to return at least 50% of adjusted FCF annually. The company reported $701M in total liquidity, $203M in cash, and a net debt to LTM adjusted EBITDA ratio of ~1x. It anticipates $600M in 2026 capex, net of asset sales, and expects to operate 104 U.S. rigs by the end of Q3.

$HPMed

The Monroe Doctrine has an oilfield test: When does the bit start to turn to the right?

The U.S. has granted North American Blue Energy Partners (NABEP) 100-year concessions for 17 Venezuelan oil fields with 65 billion barrels of reserves. The U.S. gains equity and governance rights. NABEP plans to deploy 52 drilling rigs, with some already acquired from Helmerich & Payne, Patterson-UTI Energy, and Precision Drilling. China has responded, asserting its legal rights in Venezuela. Halliburton and ExxonMobil are key players in the potential U.S.-led oil development.

$PTENMed

Is Patterson-UTI’s New Omnibus Shelf Registration Reshaping the Investment Case for PTEN?

Patterson-UTI Energy (PTEN) filed an omnibus shelf registration for potential debt, stock, and warrant issuances, enhancing its capital-raising flexibility. The company projects $5.5B revenue and $354.4M earnings by 2029, but faces risks from weak free cash flow and drilling demand. Analysts' views vary on its growth prospects, with some expecting lower revenue growth and earnings.

$PTENMed

Is Patterson-UTI (PTEN) Using Its ESOP Shelf To Quietly Reshape Capital Structure And Incentives?

Patterson-UTI Energy (PTEN) filed a shelf registration for up to 28.9 million common shares under its Employee Stock Ownership Plan. This move could influence its capital structure, governance, and workforce incentives. The company projects $5.5 billion revenue and $354.4 million earnings by 2029, but faces risks of dilution and persistent losses. Recent capital allocation includes a $500 million bond issuance and credit facility extension.

$PTENMed

UTI Energy Q2 2026: EPS Tops Estimates — Deep Dive

Patterson-UTI reported Q2 2026 breakeven adjusted EPS versus a consensus $0.04 loss, with revenue of $1.23 billion, 6.4% above forecasts. The company narrowed net loss to $19.3 million from $49.1 million and improved operating and net margins to -0.6% and -1.6%. Management guided for higher adjusted gross profit in Q3 2026.